ALS Ice Bucket Challenge Blog
Iron Horse Therapeutics Started with a Big Splash! August is the official ALS Ice Bucket Challenge month, but the team behind new San Diego biotech Iron Horse Therapeutics took the challenge to...
View ArticleAvalon Ventures Expands Collaboration with GSK and Launches Seventh New...
Under the initial collaboration, partners launch the seventh company, Iron Horse Therapeutics, developing novel treatments for ALS (amyotrophic lateral sclerosis) SAN DIEGO, Nov. 9, 2015 – Avalon...
View ArticleRepresentative Scott Peters Visits Avelas Biosciences
Congressman sees first-hand San Diego biotech and medical innovations SAN DIEGO, November 20, 2015 – Today U.S. Congressional Representative (CA-52) Scott Peters toured Avelas Biosciences, a clinical...
View ArticleRepresentative Scott Peters Visits COI Pharmaceuticals
Congressman sees first-hand San Diego biotech and medical innovations On November 20, U.S. Congressional Representative (CA-52) Scott Peters toured COI Pharmaceuticals, the Community Of Innovation....
View ArticleEnlibrium Raises $15 Million in Series A Financing for Advancement of Cancer...
Compounds derived from metformin with anti-cancer activity have been licensed from UCLA SAN DIEGO, December 3, 2015 – Enlibrium announced today that it has raised $15 million in a Series A financing...
View ArticleAvelas, AristaMD, and Synthorx recognized as Xconomy’s San Diego Life Science...
San Diego continues to be a hot bed for life science startups that are advancing technological and healthcare innovation. Within this growing community, several companies have proven to be early...
View ArticleAvalon Ventures and COI Pharmaceuticals Announce First Milestones for Sitari...
Under the expanded collaboration between Avalon Ventures and GSK, eighth company, PDI Therapeutics, is launched to develop novel immuno-oncology therapies SAN DIEGO, May 20, 2016 – Avalon Ventures...
View ArticleSynthorx Announces $10 Million Series B Financing to Develop and Scale Novel...
SAN DIEGO, July 20, 2016 — /PRNewswire/ — Synthorx Inc. announced today the completion of a $10 million Series B financing, led by RA Capital Management and joined by Series A investors Avalon Ventures...
View ArticleAristaMD Secures $11 Million Series A Financing
Digital Health Company to Enhance Functionality, Accelerate Commercialization of Referral Intelligence Platform SAN DIEGO, July 21, 2016 – AristaMD, a technology-enabled service company providing...
View ArticleAvelas Biosciences Completes $20 Million Series C Financing
Proceeds to advance AVB-620 and therapeutic programs in oncology SAN DIEGO, August 18, 2016 – Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient...
View ArticlePharmaVOICE: 15 Year Reflections and Predictions
At the beginning of the year, PharmaVOICE asked the question: Over the past 15 years the life-sciences industry has undergone a tremendous transformation, in your perspective what has been the biggest...
View ArticleAvelas, AristaMD, and Synthorx recognized as Xconomy’s San Diego Life Science...
San Diego continues to be a hot bed for life science startups that are advancing technological and healthcare innovation. Within this growing community, several companies have proven to be early...
View ArticleAvalon Ventures and COI Pharmaceuticals Announce First Milestones for Sitari...
Under the expanded collaboration between Avalon Ventures and GSK, eighth company, PDI Therapeutics, is launched to develop novel immuno-oncology therapies SAN DIEGO, May 20, 2016 – Avalon Ventures...
View ArticleUT San Diego: Avalon, GSK Form 8th San Diego Biotech
The San Diego Union-Tribune highlighted the formation of PDI Therapeutics, the eighth company formed under Avalon and GSK’s collaboration to advance early-stage biotechs. The GSK and Avalon...
View ArticleSynthorx Announces $10 Million Series B Financing to Develop and Scale Novel...
SAN DIEGO, July 20, 2016 — /PRNewswire/ — Synthorx Inc. announced today the completion of a $10 million Series B financing, led by RA Capital Management and joined by Series A investors Avalon Ventures...
View ArticleAristaMD Secures $11 Million Series A Financing
Digital Health Company to Enhance Functionality, Accelerate Commercialization of Referral Intelligence Platform SAN DIEGO, July 21, 2016 – AristaMD, a technology-enabled service company providing...
View Article